Systemic photodynamic therapy with photosensitizer photolon in the treatment of cancer patients with regional and distant metastases

The results of photodynamic therapy (PDT) in 76 patients with tumors of different sites and with regional or distant metastases are represented. Sixty three patients were under combined or multimodal therapy, 13 patients had systemic PDT as monotherapy. The technique of PDT was as follows: the solut...

Full description

Bibliographic Details
Main Authors: M. A. Kaplan, A. M. Shubina, I. A. Zamulaeva, E. I. Selivanova, E. G. Kuz’mina, N. P. Tkachenko, I. G. Zakurdyaeva, V. N. Kapinus, E. V. Goranskaya
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2014-12-01
Series:Biomedical Photonics
Subjects:
Online Access:https://www.pdt-journal.com/jour/article/view/51
_version_ 1797883719664533504
author M. A. Kaplan
A. M. Shubina
I. A. Zamulaeva
E. I. Selivanova
E. G. Kuz’mina
N. P. Tkachenko
I. G. Zakurdyaeva
V. N. Kapinus
E. V. Goranskaya
author_facet M. A. Kaplan
A. M. Shubina
I. A. Zamulaeva
E. I. Selivanova
E. G. Kuz’mina
N. P. Tkachenko
I. G. Zakurdyaeva
V. N. Kapinus
E. V. Goranskaya
author_sort M. A. Kaplan
collection DOAJ
description The results of photodynamic therapy (PDT) in 76 patients with tumors of different sites and with regional or distant metastases are represented. Sixty three patients were under combined or multimodal therapy, 13 patients had systemic PDT as monotherapy. The technique of PDT was as follows: the solution of photosensitizer photolon was administered intravenously at dose of 0.8–1.4 mg/ kg body weight. Laser blood irradiation was performed simultaneously (wavelength of 662 nm, output power of 20 mW, irradiation time of 50 min). Stabilization of the disease defined as the absence of new tumor foci was observed in 55% of treated patients: among them in 47% of patients with disseminated melanoma during 6–10 months after treatment, in 65% patients with breast cancer – for 3–6 years after treatment, and also in 100% of patients with cancer of other sites (colorectal, pancreatic, cervical, ovarian, lung and stomach cancer, retroperitoneal neuroblastoma) – for 10–12 months after treatment. According to ultrasound data the shrinkage of most of metastases up to its complete disappearance was observed. The authors consider that effects of systemic PDT are due to decrease of circulating tumor cells in blood and also due to beneficial impact of this modal of treatment on immune status of cancer patient. Intravenous PDT was shown to improve treatment results and quality of life in patients with metastases of malignant tumors. The approved technique is of considerable interest and requires further investigation of its efficiency including its combination with methods of combined and multimodal treatment.
first_indexed 2024-04-10T03:55:06Z
format Article
id doaj.art-8c3d6def61fd4a9baf3c21afc8e8aae5
institution Directory Open Access Journal
issn 2413-9432
language Russian
last_indexed 2024-04-10T03:55:06Z
publishDate 2014-12-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj.art-8c3d6def61fd4a9baf3c21afc8e8aae52023-03-13T07:12:30ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322014-12-0134182349Systemic photodynamic therapy with photosensitizer photolon in the treatment of cancer patients with regional and distant metastasesM. A. Kaplan0A. M. Shubina1I. A. Zamulaeva2E. I. Selivanova3E. G. Kuz’mina4N. P. Tkachenko5I. G. Zakurdyaeva6V. N. Kapinus7E. V. Goranskaya8Национальный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, МоскваНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияThe results of photodynamic therapy (PDT) in 76 patients with tumors of different sites and with regional or distant metastases are represented. Sixty three patients were under combined or multimodal therapy, 13 patients had systemic PDT as monotherapy. The technique of PDT was as follows: the solution of photosensitizer photolon was administered intravenously at dose of 0.8–1.4 mg/ kg body weight. Laser blood irradiation was performed simultaneously (wavelength of 662 nm, output power of 20 mW, irradiation time of 50 min). Stabilization of the disease defined as the absence of new tumor foci was observed in 55% of treated patients: among them in 47% of patients with disseminated melanoma during 6–10 months after treatment, in 65% patients with breast cancer – for 3–6 years after treatment, and also in 100% of patients with cancer of other sites (colorectal, pancreatic, cervical, ovarian, lung and stomach cancer, retroperitoneal neuroblastoma) – for 10–12 months after treatment. According to ultrasound data the shrinkage of most of metastases up to its complete disappearance was observed. The authors consider that effects of systemic PDT are due to decrease of circulating tumor cells in blood and also due to beneficial impact of this modal of treatment on immune status of cancer patient. Intravenous PDT was shown to improve treatment results and quality of life in patients with metastases of malignant tumors. The approved technique is of considerable interest and requires further investigation of its efficiency including its combination with methods of combined and multimodal treatment.https://www.pdt-journal.com/jour/article/view/51системная фотодинамическая терапияотдаленные метастазырегионарные метастазыфотолон
spellingShingle M. A. Kaplan
A. M. Shubina
I. A. Zamulaeva
E. I. Selivanova
E. G. Kuz’mina
N. P. Tkachenko
I. G. Zakurdyaeva
V. N. Kapinus
E. V. Goranskaya
Systemic photodynamic therapy with photosensitizer photolon in the treatment of cancer patients with regional and distant metastases
Biomedical Photonics
системная фотодинамическая терапия
отдаленные метастазы
регионарные метастазы
фотолон
title Systemic photodynamic therapy with photosensitizer photolon in the treatment of cancer patients with regional and distant metastases
title_full Systemic photodynamic therapy with photosensitizer photolon in the treatment of cancer patients with regional and distant metastases
title_fullStr Systemic photodynamic therapy with photosensitizer photolon in the treatment of cancer patients with regional and distant metastases
title_full_unstemmed Systemic photodynamic therapy with photosensitizer photolon in the treatment of cancer patients with regional and distant metastases
title_short Systemic photodynamic therapy with photosensitizer photolon in the treatment of cancer patients with regional and distant metastases
title_sort systemic photodynamic therapy with photosensitizer photolon in the treatment of cancer patients with regional and distant metastases
topic системная фотодинамическая терапия
отдаленные метастазы
регионарные метастазы
фотолон
url https://www.pdt-journal.com/jour/article/view/51
work_keys_str_mv AT makaplan systemicphotodynamictherapywithphotosensitizerphotoloninthetreatmentofcancerpatientswithregionalanddistantmetastases
AT amshubina systemicphotodynamictherapywithphotosensitizerphotoloninthetreatmentofcancerpatientswithregionalanddistantmetastases
AT iazamulaeva systemicphotodynamictherapywithphotosensitizerphotoloninthetreatmentofcancerpatientswithregionalanddistantmetastases
AT eiselivanova systemicphotodynamictherapywithphotosensitizerphotoloninthetreatmentofcancerpatientswithregionalanddistantmetastases
AT egkuzmina systemicphotodynamictherapywithphotosensitizerphotoloninthetreatmentofcancerpatientswithregionalanddistantmetastases
AT nptkachenko systemicphotodynamictherapywithphotosensitizerphotoloninthetreatmentofcancerpatientswithregionalanddistantmetastases
AT igzakurdyaeva systemicphotodynamictherapywithphotosensitizerphotoloninthetreatmentofcancerpatientswithregionalanddistantmetastases
AT vnkapinus systemicphotodynamictherapywithphotosensitizerphotoloninthetreatmentofcancerpatientswithregionalanddistantmetastases
AT evgoranskaya systemicphotodynamictherapywithphotosensitizerphotoloninthetreatmentofcancerpatientswithregionalanddistantmetastases